Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel
Determining the cause of Atypical Myopathy
Scientists find toxic acid in pasture seeds

A toxin found in box elder seeds has been linked to atypical myopathy (AM), after a connection was was made between the seeds and the US equivalent of the disease – seasonal pasture myopathy (SPM).

US scientists conducted research into the cause of SPM, which has been published in the Equine Veterinary Journal (EVJ).

They found that the toxic amino acid, hypoglycin A, was present in the serum or urine of horses with clinical signs of SPM. Hypoglycin A was also found in the seeds of box elder trees, therefore, the scientists believe it is this that creates the disease's pathology.

Box elder seeds are abundant in autumn pastures, which is when the highly fatal muscle conditions SPM and AM most commonly occur.

Symptoms include muscular weakness and stiffness, dark urine, periods of recumbency, colic-like signs and muscle-trembling. The conditions tend to develop in horses that are kept in sparse pastures, with dead leaves, dead wood and trees.

The scientists enrolled 12 horses from 11 different farms for their study, all with typical clinical signs of SPM. Hypoglacin A was found in either the serum or urine of all 12 horses, and all but one case proved to be fatal.

Hypoglycin A is also known to cause acquired multiple acyl CoA dehydrogenase deficiency (MADD).

Professor Valberg, from the College of Veterinary Medicine at the University of Minnesota, who led the study, said: "The fact that another acquired form of MADD in rats and humans is caused by hypoglycin A ingestion strengthens our conclusion that hypoglycin A is the likely toxic cause of SPM in horses.

"We are intending to conduct further studies to determine the factors that affect the highly variable hypoclycin A concentrations in box elder seeds."

EVJ Editor Celia Marr said: “This is a really important step forwards. We don’t yet know for sure that the cause of European disease, AM, is the same as SPM in the US, but the clinical signs and MADD aberrations are identical and both conditions have a high fatality rate.

"It remains to be seen whether this research will help European horses, but there is no doubt that it will allow American horse owners to prevent this devastating condition affecting their horses with immediate effect.”

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.